Holen Sie sich die Stockscreener-App
13.91
0.11%
0.02
Schlusskurs vom Vortag:
$13.89
Offen:
$13.75
24-Stunden-Volumen:
78,238
Relative Volume:
0.11
Marktkapitalisierung:
$814.70M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
14.64
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
+0.25%
1M Leistung:
+35.13%
6M Leistung:
-1.38%
1J Leistung:
+3.54%
1-Tages-Spanne:
$13.75
$14.02
1-Wochen-Bereich:
$13.35
$14.09
52-Wochen-Spanne:
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Vergleichen Sie EMBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
13.93 | 788.38M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
476.35 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
198.31 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
79.11 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.47 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
243.46 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | Eingeleitet | BTIG Research | Neutral |
| 2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
Traders Consider Averaging Down in Embecta Corp.2025 Retail Activity & Weekly Watchlist of Top Performers - classian.co.kr
Pen Needles Company Evaluation Report 2025 | Embecta, Novo Nordisk, and B. Braun Dominate with Strong Portfolios, Innovation, and Expansive Distribution - Yahoo Finance
RSI Crosses Above 30 for Embecta Corp. — Reversal in Sight2025 Technical Overview & Low Risk Investment Opportunities - beatles.ru
Is now a turning point for Embecta Corp.Quarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
Why Embecta Corp. stock attracts strong analyst attention2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Historical volatility pattern of Embecta Corp. visualizedInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Embecta Corp. stock outlook for YEARPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
What MACD signals say about Embecta Corp.Portfolio Risk Summary & Fast Gaining Stock Strategy Reports - Newser
Will Embecta Corp. see short term momentumJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Visual trend scoring systems applied to Embecta Corp.Trade Performance Summary & Weekly Watchlist of Top Performers - Newser
Pattern Scan Adds Embecta Corp. to WatchlistJuly 2025 Reactions & Safe Entry Momentum Stock Tips - thegnnews.com
Are Embecta's (EMBC) Earnings Growth Sustainable Amid Operational Headwinds and Geopolitical Risks? - AInvest
Embecta's (NASDAQ:EMBC) Profits May Not Reveal Underlying Issues - Yahoo Finance
Will Embecta Corp. benefit from macro trendsWeekly Trading Summary & Verified Momentum Stock Watchlist - Newser
Embecta Corp. stock trend forecastExit Point & Daily Technical Forecast Reports - Newser
PNC Financial Services Group Inc. Has $343,000 Stake in Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta (NASDAQ:EMBC) Stock Rating Upgraded by Wall Street Zen - Defense World
What’s the recovery path for long term holders of Embecta Corp.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Is Embecta Corp. building a consolidation baseMarket Rally & Real-Time Volume Analysis Alerts - Newser
Embecta Corp. Reports Record Revenue and Debt Reduction - MSN
Can swing trading help recover from Embecta Corp. lossesPortfolio Return Summary & Low Risk Growth Stock Ideas - Newser
Embecta Corp. (NASDAQ:EMBC) Q3 2025 Earnings Call Transcript - MSN
Day 5 of Gains Streak for Embecta Stock with 41% Return (vs. -31% YTD) [8/13/2025] - Trefis
Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know - NewsBreak: Local News & Alerts
Natixis Advisors LLC Sells 7,984 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta To Go Ex-Dividend On August 29th, 2025 With 0.15 USD Dividend Per Share - 富途牛牛
Intraday Charts Show Spike in Embecta Corp. ActivitySecure Return Focused Investment Plan Released - beatles.ru
Market Cool On Embecta Corp.'s (NASDAQ:EMBC) Earnings - 富途牛牛
Embecta Corp. shares rise 1.06% intraday due to positive outlook in the insulin delivery device market. - AInvest
Embecta Corp (EMBC) Stock: A Year of Stock Market Dynamics - investchronicle.com
Mizuho raises Embecta stock price target to $14 on strong Q3 results - Investing.com Nigeria
Mizuho raises Embecta stock price target to $14 on strong Q3 results By Investing.com - Investing.com South Africa
Bloomberg Finance Expert Creates Essential Title for News Passage - AInvest
What makes Embecta Corp. stock price move sharplySmart Exit Timing Suggestions - mustnews.co.kr
Can Embecta Corp. deliver consistent EPS growthFree Entry and Exit Planner - sisaissue.com
Embecta Corp's Q3 2025 Outperformance: A Strategic Re-rating Opportunity Amid Margin Stability and Debt Reduction - AInvest
Embecta's 2025 Revenue Outlook: Navigating Regional Challenges and Valuation Opportunities - AInvest
This Embecta Insider Increased Their Holding By 20% Last Year - simplywall.st
Wyckoff Accumulation Phase Possible in Embecta Corp.Swing Trade Entry With Volume Triggers Released - beatles.ru
Embecta 2025 Q3 Earnings Strong Performance as Net Income Surges 209.5% - AInvest
Embecta outlines revenue range of $1.078B-$1.085B for 2025 amid U.S. strength and China headwinds - MSN
Embecta (NASDAQ:EMBC) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Embecta Corporation Reports Strong Q3 2025 Results - TipRanks
What are the risks of holding Embecta Corp.Weekly Alpha Generating Watchlist - thegnnews.com
Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest
Embecta Beat Estimates And Raised Its Outlook For The Year - Finimize
Embecta (EMBC.O) Surges 16.55% — But No News. What’s Driving This Move? - AInvest
Embecta Shares Rise on 2Q Profit, Revenue Beat - 富途牛牛
Embecta stock gets a boost on Q3 beats, raised guidance - Drug Delivery Business
Embecta Q3 2025 Earnings Call Transcript - MarketBeat
Embecta Corp.'s Q3 2025 Earnings Call: Navigating Key Contradictions in Tariffs, Demand, and Financial Strategy - AInvest
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Embecta Corp-Aktie (EMBC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):